The Alzheimer's Disease Research Center (ADRC) will build upon research strength at the College of Physicians and Surgeons of Columbia University and combine these with the research experience and clinical care activities at the Burke Rehabilitation Center of Cornell University. By this means, we hope to use the ADRC to bridge the academic activity in these two major clinical and research universities in New York City. In turn, the Center at these two universities will integrate activities at other institutions, such as investigations of cortical connectivity and protein phosphorylation at Rockefeller University, and serve as a focus for investigators throughout the greater New York area. This Alzheimer's Disease Research Center emphasizes research in cell and molecular biology, including the molecular basis of memory, combined with strong research on the clinical aspects of Alzheimer's Disease and the care of Alzheimer's patients. It will include four new research programs in the cellular and molecular mechanisms underlying normal and disordered neuronal growth and neuronal plasticity. These studies will be carried out in parallel with clinical research on the natural history of Alzheimer's Disease and the care of Alzheimer Disease patients. The diversity of different ethnic, racial and economic backgrounds of patients in our populations will provide a unique chance to study how these factors influence care and outcome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-02
Application #
3104904
Study Section
Aging Review Committee (AGE)
Project Start
1989-09-29
Project End
1994-05-31
Budget Start
1990-09-15
Budget End
1991-05-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361

Showing the most recent 10 out of 640 publications